Impact of a mHealth Intervention in Type 2 Diabetes Mellitus Patients: A Randomized Clinical Trial

• Published in: SN comprehensive clinical medicine 2023-09, Vol.5 (1), Article 219
• Main Authors: Hoda, Farazul, Arshad, Mawrah, Khan, Mohammad Ahmed, Kohli, Sunil, Kareem, Shahid, Akhtar, Mohd, Najmi, Abul Kalam
• Format: Article
• Language: English
• Subjects: Medicine; Medicine & Public Health; Original Paper; Topical Collection on Medicine
• ISSN: 2523-8973; 2523-8973
• DOI: 10.1007/s42399-023-01564-3

To evaluate the impact of mHealth (Mobile Health) intervention on glycaemic control and secondary outcomes in patients with Type 2 Diabetes Mellitus (T2DM). This was a 3 month open-label randomized control parallel arm study. The study was conducted in the outpatient department of Hakeem Abdul Hameed Centenary Hospital, Jamia Hamdard, New Delhi. 100 participants with Type 2 Diabetes Mellitus patients ( n  = 50 intervention, n  = 50 control). Intervention group received (routine diabetes care + 3–5 messages and a call every week) and control group (routine diabetes care). Messages and calls were delivered by a trained pharmacist through mobile phone manually. The primary outcome measure was change in HbA1c (Glycated Haemoglobin) at baseline and at the end of the follow-up after 3 months. 100 patients with T2DM were randomized to the intervention and control groups ( n  = 50). HbA1c level decreased by 0.95% in the intervention group compared with 0.48% in the controls (0.59; 95% confidence interval [CI] –0.27 to 1.17) at 6 months. ( p